Literature DB >> 8682069

Aldosterone: intracellular receptors in human heart.

J P Bonvalet1, N Alfaidy, N Farman, M Lombès.   

Abstract

It has been suggested that aldosterone exerts direct effects on heart functioning, in particular by inducing cardiac fibrosis. We examined human heart tissue for the expression of aldosterone receptors (mineralocorticoid receptors, MRs) and of the MR-protecting enzyme, 11 beta hydroxysteroid dehydrogenase (11 beta HSD). In situ hybridization using cRNA probes specific for human MRs revealed the presence of mRNA encoding for MRs in cardiomyocytes. Immunohistochemistry with specific antibodies against the MR exhibited the expression of MR protein in cardiomyocytes. In contrast, intramyocardial small blood vessels showed no evidence of immunolabelling. A distinct 11 beta HSD activity, which was nicotinamide-adenine dinucleotide dependent, was also demonstrated in human cardiac tissue. These results illustrate that all the components required for a specific aldosterone effect are present in the human heart.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8682069     DOI: 10.1093/eurheartj/16.suppl_n.92

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  9 in total

Review 1.  Aldosterone as a determinant of cardiovascular and renal dysfunction.

Authors:  M Epstein
Journal:  J R Soc Med       Date:  2001-08       Impact factor: 5.344

Review 2.  Aldosterone in the pathogenesis of chronic kidney disease and proteinuria.

Authors:  Yee Lu; Elaine Ku; Vito M Campese
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

Review 3.  Aldosterone breakthrough during RAS blockade: a role for endothelins and their antagonists?

Authors:  Gian Paolo Rossi
Journal:  Curr Hypertens Rep       Date:  2006-06       Impact factor: 5.369

4.  Contrasting effects of eplerenone and spironolactone on adrenal cell steroidogenesis.

Authors:  P Ye; T Yamashita; D M Pollock; H Sasano; W E Rainey
Journal:  Horm Metab Res       Date:  2008-09-25       Impact factor: 2.936

Review 5.  Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure.

Authors:  Navneet S Rehsia; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2010-01       Impact factor: 4.214

6.  The prevalence of primary aldosteronism in diabetic patients.

Authors:  Dijana Jefic; Naushaba Mohiuddin; Rana Alsabbagh; Margaret Fadanelli; Susan Steigerwalt
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-04       Impact factor: 3.738

Review 7.  The role of aldosterone in resistant hypertension: implications for pathogenesis and therapy.

Authors:  Murray Epstein; David A Calhoun
Journal:  Curr Hypertens Rep       Date:  2007-04       Impact factor: 4.592

8.  Safety evaluation and cardiovascular effect of additional use of spironolactone in hemodialysis patients: a meta-analysis.

Authors:  Qing Zeng; XiaoDuo Zhou; Ge Xu
Journal:  Drug Des Devel Ther       Date:  2019-05-03       Impact factor: 4.162

9.  Identification of Mineralocorticoid Receptors, Aldosterone, and Its Processing Enzyme CYP11B2 on Parasympathetic and Sympathetic Neurons in Rat Intracardiac Ganglia.

Authors:  Lukas Dehe; Shaaban A Mousa; Noureddin Aboryag; Mohammed Shaqura; Antje Beyer; Michael Schäfer; Sascha Treskatsch
Journal:  Front Neuroanat       Date:  2022-01-11       Impact factor: 3.856

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.